In addition, the mean methylation of the SFRP2 gene was significantly higher in CRC than in benign mucosal lesions (0.72 vs 0.38), which indicated that detection of SFRP2 methylation could be a promising noninvasive biomarker for the diagnosis of CRC using feces. Here, SFRP2 is linked to colorectal carcinoma.